News for Sangamo BioSciences, Inc. (SGMO)

News for Sangamo BioSciences, Inc.
Date Headline
Jan 13, 2017 09:23 AM Biotech Premarket Movers: SGMO, IPXL, PTLA
Jan 12, 2017 01:04 PM SANGAMO THERAPEUTICS INC Financials
Jan 11, 2017 09:08 AM Biotech Premarket Movers: IPXL, SGMO, ARLZ
Jan 11, 2017 07:30 AM Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-318 Genome Editing Treatment for MPS I
Jan 10, 2017 08:00 AM Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform Technology At Keystone Symposium On Precision Genome Engineering
Jan 06, 2017 08:16 AM SANGAMO BIOSCIENCES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia
Jan 06, 2017 08:00 AM Sangamo BioSciences Changes Name To Sangamo Therapeutics, Underscoring Focus On Clinical Development Of Genomic Therapies
Jan 05, 2017 08:04 AM Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A
Jan 05, 2017 08:00 AM Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A
Jan 04, 2017 04:05 PM Sangamo BioSciences Announces Presentation At The 35th Annual J.P. Morgan Healthcare Conference